Internal Medicine, Pulmonary Disease · Phoenixville, PA
NPI
1861588006
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
826 Main Street, Suite 100
Phoenixville, PA, 19460
Phone (610) 933-8484
Groups this clinician bills Medicare through
Medicare paid, 2024
$273K
4,457 services
Medicare patients, 2024
1,246
Average age 75
Drug cost, 2024
$1.7M
5,640 prescriptions
Company payments, 2025
$34.92
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymond Kovalski was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 979 times for 621 patients. In total Raymond Kovalski billed 4,457 services in 41 codes, and Medicare paid $273K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 979 | 621 | $12.74 | $12K |
| 99213 Office E&M - Established | Office | 688 | 506 | $67.06 | $46K |
| 99232 Hospital E&M - Subsequent | Facility | 685 | 236 | $62.33 | $43K |
| 99214 Office E&M - Established | Office | 472 | 319 | $95.07 | $45K |
| 99223 Hospital E&M - Initial | Facility | 220 | 191 | $136.03 | $30K |
| 99233 Hospital E&M - Subsequent | Facility | 191 | 60 | $91.82 | $18K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 164 | 163 | $73.44 | $12K |
| 95806 Sleep Study | Office | 162 | 161 | $33.38 | $5,408 |
| 94729 Pulmonary Function Testing | Office | 108 | 108 | $28.75 | $3,105 |
| 94060 Pulmonary Function Testing | Office | 100 | 100 | $19.78 | $1,978 |
| 99203 Office E&M - New | Office | 85 | 85 | $80.58 | $6,849 |
| 94726 Pulmonary Function Testing | Office | 63 | 63 | $42.81 | $2,697 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 58 | 58 | $132.80 | $7,703 |
| 94060 Pulmonary Function Testing | Facility | 46 | 46 | $6.65 | $306 |
| 94729 Pulmonary Function Testing | Facility | 46 | 46 | $5.79 | $266 |
By year: 2022 $224K for 3,111 services; 2023 $249K for 3,395 services; 2024 $273K for 4,457 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raymond Kovalski prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 566 prescriptions and refills. In total Raymond Kovalski wrote 5,640 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 566 | 698 | 96 | $431K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 486 | 553 | 184 | $14K |
| Prednisone Generic | 249 | 295 | 110 | $1,178 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 225 | 289 | 34 | $128K |
| Breo Ellipta Fluticasone/Vilanterol | 169 | 228 | 36 | $87K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 151 | 196 | 36 | $20K |
| Montelukast Sodium Generic | 145 | 307 | 35 | $1,305 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 143 | 177 | 27 | $82K |
| Atorvastatin Calcium Generic | 137 | 353 | 34 | $1,514 |
| Xarelto Rivaroxaban | 132 | 217 | 25 | $125K |
| Spiriva Respimat Tiotropium Bromide | 127 | 165 | 38 | $83K |
| Ventolin Hfa Albuterol Sulfate | 111 | 116 | 30 | $6,662 |
| Clonazepam Generic | 111 | 143 | 19 | $742 |
| Lisinopril Generic | 110 | 254 | 23 | $619 |
| Symbicort Budesonide/Formoterol Fumarate | 94 | 152 | 32 | $32K |
Brand drugs: 2,513 claims; generic drugs: 3,112 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymond Kovalski $34.92 ($34.92 in general payments such as food, travel and fees) from 1 company. The largest payer was Siemens Medical Solutions USA, Inc. with $34.92.
| Company | Payments | Amount |
|---|---|---|
| Siemens Medical Solutions USA, Inc. SHL.DE | 1 | $34.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.